Literature DB >> 18230793

Improving outcomes for patients with hormone receptor-positive breast cancer: back to the drawing board.

Matthew J Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18230793     DOI： 10.1093/jnci/djm325

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  1 in total

1.  Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.

Authors:  Golareh Habibi; Samuel Leung; Jennifer H Law; Karen Gelmon; Hamid Masoudi; Dmitry Turbin; Michael Pollak; Torsten O Nielsen; David Huntsman; Sandra E Dunn
Journal:  Breast Cancer Res       Date:  2008-10-16       Impact factor: 6.466
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.